Curis | CRIS - تكلفة المبيعات





تكلفة المبيعات تغيير تاريخ
Alaunos Therapeutics USD 0 18K 2024-09
Amgen USD 1.6B 187M 2026-03
AstraZeneca USD -204M 3.48B 2026-03
Bayer EUR 5.23B 731M 2026-03
Bristol-Myers Squibb USD 3.86B 1.07B 2026-03
CSL USD 3.87B 2.08B 2025-12
Curis USD 314K 9.96M 2025-12
Eli Lilly USD 3.58B 205M 2026-03
Exelixis USD 19.95M 6.53M 2026-03
Gilead Sciences USD 1.44B 174M 2026-03
GlaxoSmithKline GBP 1.88B 736M 2026-03
Incyte USD 104.5M 16.68M 2026-03
Merck USD 2.94B 380M 2026-03
Novartis USD 3.46B 83M 2026-03
Pfizer USD 4.59B 1.7B 2026-03
Roche Holding CHF 8.48B 4.61B 2025-12
Sanofi EUR 3.67B 621M 2026-03
Takeda JPY 560.54B 159.39B 2026-03
TG Therapeutics USD 33.51M 4.63M 2026-03
Verastem USD 2.89M 2.88M 2025-12
Xoma 116K 112.7K 2024-06